Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05139017
Title A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | FRA | CAN

Facility Status City State Zip Country Details
Innovative Clinical Research Institute ( Site 0122) COMPLETED Whittier California 90603 United States Details
Norton Women's and Children's Hospital-Norton Cancer Institute - St. Matthews ( Site 0133) RECRUITING Louisville Kentucky 40207 United States Details
Louisiana State University Health Sciences Center New Orleans ( Site 0134) COMPLETED New Orleans Louisiana 70112 United States Details
University of Maryland ( Site 0123) COMPLETED Baltimore Maryland 21201 United States Details
Dana-Farber Cancer Institute-Lymphoma ( Site 0111) RECRUITING Boston Massachusetts 02215 United States Details
University of Massachusetts Medical School ( Site 0119) RECRUITING Worcester Massachusetts 01655 United States Details
St. Vincent Frontier Cancer Center-Research ( Site 0108) RECRUITING Billings Montana 59102 United States Details
Atlantic Health System ( Site 0116) RECRUITING Morristown New Jersey 07960 United States Details
New York Medical College ( Site 0113) RECRUITING Valhalla New York 10595 United States Details
Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 0156) RECRUITING Nashville Tennessee 37232 United States Details
Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0200) COMPLETED Toronto Ontario M5G 2M9 Canada Details
Beijing Cancer hospital ( Site 3000) RECRUITING Beijing Beijing 100142 China Details
Chongqing University Cancer Hospital-Medical Oncology ( Site 3025) RECRUITING Chongqing Chongqing 400030 China Details
Chongqing University Three Gorges Hospital ( Site 3026) RECRUITING Chongqing Chongqing 404199 China Details
Sun Yat-sen University Cancer Center-Internal Medicine ( Site 3001) RECRUITING Guangzhou Guangdong 510030 China Details
Zhujiang Hospital ( Site 3002) RECRUITING Guangzhou Guangdong 510280 China Details
Henan Cancer Hospital-hematology department ( Site 3013) RECRUITING Zhengzhou Henan 450008 China Details
Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 3017) RECRUITING Wuhan Hubei 430010 China Details
The First Affiliated Hospital of Nanchang University ( Site 3004) RECRUITING Nanchang Jiangxi 330006 China Details
Jiangxi Provincial Cancer Hospital ( Site 3005) RECRUITING Nanchang Jiangxi 330029 China Details
centre hospitalier lyon sud-Service Hématologie ( Site 0702) RECRUITING Pierre-Bénite Rhone 69310 France Details
Pitie Salpetriere University Hospital-Clinical haematology ( Site 0700) RECRUITING Paris 75013 France Details
Emek Medical Center-Hematology Unit ( Site 1102) RECRUITING Afula 1834111 Israel Details
Carmel Hospital ( Site 1103) RECRUITING Haifa 3436212 Israel Details
Hadassah Medical Center ( Site 1100) RECRUITING Jerusalem 9112001 Israel Details
Fondazione Policlinico Universitario Agostino Gemelli IRCCS -ISTITUTO DI EMATOLOGIA ( Site 1204) RECRUITING Roma Lazio 00168 Italy Details
Humanitas-U.O di Oncologia medica ed Ematologia ( Site 1203) RECRUITING Rozzano Milano 20089 Italy Details
IRCCS - AOU di Bologna-Istituto di Ematologia "L. e A. Seragnoli" ( Site 1200) COMPLETED Bologna 40138 Italy Details
Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 1202) RECRUITING Napoli 80131 Italy Details
Seoul National University Hospital-Oncology ( Site 0302) RECRUITING Seoul 03080 Korea, Republic of Details
Samsung Medical Center ( Site 0300) RECRUITING Seoul 06351 Korea, Republic of Details
Uniwersytecki Szpital Kliniczny-Klinika Hematologii, Nowotworow Krwi i Transplantacji Szpiku ( Site COMPLETED Wroclaw Dolnoslaskie 50-367 Poland Details
Centrum Onkologii Ziemi Lubelskiej-Oddzial Hematologii i Transplantacji Szpiku ( Site 1304) RECRUITING Lublin Lubelskie 20-090 Poland Details
Pratia MCM Krakow ( Site 1303) RECRUITING Krakow Malopolskie 30-727 Poland Details
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworów Układu Chłonnego ( S RECRUITING Warszawa Mazowieckie 02-781 Poland Details
Szpitale Pomorskie Sp. z o. o.-Hematology and Bone Marrow Transplantation Department ( Site 1302) COMPLETED Gdynia Pomorskie 81-519 Poland Details
Maharaj Nakorn Chiang Mai Hospital ( Site 0401) RECRUITING Muang Chiang Mai 50200 Thailand Details
Faculty of Medicine Siriraj Hospital-Division of Hematology, Department of Medicine ( Site 0400) RECRUITING Bangkok Krung Thep Maha Nakhon 10700 Thailand Details
Ege University Medicine of Faculty ( Site 1902) RECRUITING Bornova Izmir 35100 Turkey Details
Ankara University Hospital Cebeci-hematology ( Site 1901) RECRUITING Ankara 06100 Turkey Details
Mega Medipol-Hematology ( Site 1909) RECRUITING Istanbul 34214 Turkey Details
Dokuz Eylül Üniversitesi-Hematology ( Site 1905) RECRUITING Izmir 35340 Turkey Details
Ondokuz Mayıs Universitesi ( Site 1907) COMPLETED Samsun 55139 Turkey Details
University College London Hospital-Cancer Clinical Trials Unit ( Site 2100) RECRUITING London-Camden London, City Of NW1 2PG United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field